Home

cowboy Kosár Kábító from nature rev immunol pardoll dm 2012 Szobrász kérés nyilatkozat

Frontiers | Diversity of immune checkpoints in cancer immunotherapy
Frontiers | Diversity of immune checkpoints in cancer immunotherapy

Adoptive immunotherapy for cancer: harnessing the T cell response | Nature  Reviews Immunology
Adoptive immunotherapy for cancer: harnessing the T cell response | Nature Reviews Immunology

Technological advances in cancer immunity: from immunogenomics to  single-cell analysis and artificial intelligence | Signal Transduction and  Targeted Therapy
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence | Signal Transduction and Targeted Therapy

Immune checkpoint - Wikipedia
Immune checkpoint - Wikipedia

Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the  Occurrence of AKI: Where Do We Stand?
Frontiers | The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?

Dendritic cells in cancer immunology | Cellular & Molecular Immunology
Dendritic cells in cancer immunology | Cellular & Molecular Immunology

Cancer immunotherapy via dendritic cells | Nature Reviews Cancer
Cancer immunotherapy via dendritic cells | Nature Reviews Cancer

Frontiers | What Happens to the Immune Microenvironment After PD-1  Inhibitor Therapy?
Frontiers | What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

Vaccines | Free Full-Text | Targeting Innate Immunity in Cancer Therapy
Vaccines | Free Full-Text | Targeting Innate Immunity in Cancer Therapy

Cancers | Free Full-Text | Recent Advances and Challenges in Cancer  Immunotherapy
Cancers | Free Full-Text | Recent Advances and Challenges in Cancer Immunotherapy

Immune-checkpoint inhibitors: long-term implications of toxicity | Nature  Reviews Clinical Oncology
Immune-checkpoint inhibitors: long-term implications of toxicity | Nature Reviews Clinical Oncology

Coordinated regulation of myeloid cells by tumours | Nature Reviews  Immunology
Coordinated regulation of myeloid cells by tumours | Nature Reviews Immunology

Tumour-intrinsic resistance to immune checkpoint blockade | Nature Reviews  Immunology
Tumour-intrinsic resistance to immune checkpoint blockade | Nature Reviews Immunology

The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews  Cancer
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer

Molecular and cellular insights into T cell exhaustion | Nature Reviews  Immunology
Molecular and cellular insights into T cell exhaustion | Nature Reviews Immunology

Novel immunotherapies in lymphoid malignancies | Nature Reviews Clinical  Oncology
Novel immunotherapies in lymphoid malignancies | Nature Reviews Clinical Oncology

Adoptive immunotherapy for cancer: harnessing the T cell response | Nature  Reviews Immunology
Adoptive immunotherapy for cancer: harnessing the T cell response | Nature Reviews Immunology

Targeting neoantigens to augment antitumour immunity | Nature Reviews Cancer
Targeting neoantigens to augment antitumour immunity | Nature Reviews Cancer

The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews  Cancer
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer

Natural killer cells and immune-checkpoint inhibitor therapy: Current  knowledge and new challenges: Molecular Therapy - Oncolytics
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges: Molecular Therapy - Oncolytics

CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting  NK cells and acting as immunocheckpoint blockade: Molecular Therapy -  Nucleic Acids
CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade: Molecular Therapy - Nucleic Acids

Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint  Blockade Therapies
Frontiers | The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies

Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer  therapy | Nature Reviews Cancer
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy | Nature Reviews Cancer

Sizing up the key determinants of the CD8+ T cell response | Nature Reviews  Immunology
Sizing up the key determinants of the CD8+ T cell response | Nature Reviews Immunology

Immune cell promotion of metastasis | Nature Reviews Immunology
Immune cell promotion of metastasis | Nature Reviews Immunology

The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews  Cancer
The blockade of immune checkpoints in cancer immunotherapy | Nature Reviews Cancer

Tuning immunity through tissue mechanotransduction | Nature Reviews  Immunology
Tuning immunity through tissue mechanotransduction | Nature Reviews Immunology

Cancer immunotherapy — immune checkpoint blockade and associated  endocrinopathies | Nature Reviews Endocrinology
Cancer immunotherapy — immune checkpoint blockade and associated endocrinopathies | Nature Reviews Endocrinology